Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions

被引:85
作者
Kohlhammer, H
Schwaenen, C
Wessendorf, S
Holzmann, K
Kestler, HA
Kienle, D
Barth, TFE
Möller, P
Ott, G
Kalla, J
Radlwimmer, B
Pscherer, A
Stilgenbauer, S
Döhner, H
Lichter, P
Bentz, M [1 ]
机构
[1] Univ Ulm, Med Klin, Abt Innere Med 3, D-89081 Ulm, Germany
[2] Univ Ulm, Med Klin, Dept Innere Med 1, D-89081 Ulm, Germany
[3] Univ Ulm, Dept Neuroinformat, Ulm, Germany
[4] Univ Ulm, Dept Pathol, Ulm, Germany
[5] Univ Wurzburg, Dept Pathol, D-8700 Wurzburg, Germany
[6] Deutsch Krebsforschungszentrum, Dept Mol Genet, D-6900 Heidelberg, Germany
关键词
D O I
10.1182/blood-2003-12-4175
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tumor samples of 53 patients with t(11;14)-positive mantle cell lymphomas (MCLs) were analyzed by matrix-based comparative genomic hybridization (matrix-CGH) using a dedicated DNA array. In 49 cases, genomic aberrations were identified. In comparison to chromosomal CGH, a 50%. higher number of aberrations was found and the high specificity of,matrix-CGH was demonstrated by fluorescence in situ hybridization (FISH) analyses. The 11q gains and 13q34 deletions, which have not been described as frequent genomic aberrations in MCL, were identified by matrix-CGH in 15 and 26 cases, respectively. For several genomic aberrations, novel consensus regions were defined: 8p21 (size of the consensus region, 2.4 megabase pairs [Mbp]; candidate genes: TNFRSF10B, TNFRSF10C, TNFRSF10D); 10p13 (2.7 Mbp; BM/1); 11q13 (1.4 Mbp; RELA); 11q13 (5.2 Mbp; CCND1); 13q14 (0.4 Mbp; RFP2, BCMSUN) and 13q34 (6.9 Mbp). In univariate analyses correlating genomic aberrations and clinical course, 8p- and 13q14- deletions were associated with an inferior overall survival. These data provide a basis for further studies focusing on the identification of pathogenetically or clinically relevant genes, in MCL.
引用
收藏
页码:795 / 801
页数:7
相关论文
共 62 条
  • [1] Identification of novel regions of amplification and deletion within mantle cell lymphoma DNA by comparative genomic hybridization
    Allen, JE
    Hough, RE
    Goepel, JR
    Bottomley, S
    Wilson, GA
    Alcock, HE
    Baird, M
    Lorigan, PC
    Vandenberghe, EA
    Hancock, BW
    Hammond, DW
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2002, 116 (02) : 291 - 298
  • [2] The inv(11)(p15q22) chromosome translocation of de novo and therapy-related myeloid malignancies results in fusion of the nucleoporin gene, NUP98, with the putative RNA helicase gene, DDX10
    Arai, Y
    Hosoda, F
    Kobayashi, H
    Arai, K
    Hayashi, Y
    Kamada, N
    Kaneko, Y
    Ohki, M
    [J]. BLOOD, 1997, 89 (11) : 3936 - 3944
  • [3] Mantle cell lymphoma: A clinicopathologic study of 80 cases
    Argatoff, LH
    Connors, JM
    Klasa, RJ
    Horsman, DE
    Gascoyne, RD
    [J]. BLOOD, 1997, 89 (06) : 2067 - 2078
  • [4] Cytogenetic analysis in mantle cell lymphoma: A review of 214 cases
    Au, WY
    Gascoyne, RD
    Viswanatha, DS
    Connors, JM
    Klasa, RJ
    Horsman, DE
    [J]. LEUKEMIA & LYMPHOMA, 2002, 43 (04) : 783 - 791
  • [5] Mantle-cell lymphoma
    Barista, Ibrahim
    Romaguera, Jorge E.
    Cabanillas, Fernando
    [J]. LANCET ONCOLOGY, 2001, 2 (03) : 141 - 148
  • [6] Beà S, 1999, BLOOD, V93, P4365
  • [7] Beà S, 2001, CANCER RES, V61, P2409
  • [8] Bentz M, 1998, GENE CHROMOSOME CANC, V21, P172, DOI 10.1002/(SICI)1098-2264(199802)21:2<172::AID-GCC14>3.3.CO
  • [9] 2-T
  • [10] Bentz M, 2000, GENE CHROMOSOME CANC, V27, P285, DOI 10.1002/(SICI)1098-2264(200003)27:3<285::AID-GCC9>3.3.CO